GenomeIndia: Pioneering Precision Medicine in India | ORF

A large-scale genomic study of the Indian population, known as GenomeIndia, is revealing a more complex landscape of disease risk, drug response, and previously underdiagnosed metabolic conditions than current medical averages suggest. The project, launched in January 2020, aims to build a comprehensive catalog of genetic variations specific to the Indian population, paving the way for more targeted and effective healthcare solutions.

The GenomeIndia initiative is a collaboration involving 20 academic and research institutions across India, coordinated by the Centre for Brain Research at the Indian Institute of Science (IISc) in Bengaluru. Key participating institutes include BRIC-NIBMG, CSIR-CCMB, and CSIR-IGIB, alongside numerous sample-collection partners nationwide.

Mapping Genetic Diversity

The human genome, comprised of approximately three billion DNA letters (A, C, G, and T), is the blueprint for life. Individuals inherit half of their DNA from each parent, resulting in genetic variations that influence disease susceptibility and drug response. On average, genetic codes differ at about one in 1,000 positions between any two individuals. GenomeIndia seeks to sequence the whole genomes of 10,000 individuals from 83 diverse Indian populations to capture this genetic richness.

Understanding these genetic nuances is crucial for deciphering predispositions to certain diseases and designing effective treatments. A reference set of genetic variants specific to the Indian population will contribute to a better understanding of disease patterns and enable tailored interventions for diverse ethnic groups.

Data Collection and Accessibility

Beyond genomic sequencing, GenomeIndia includes the collection and storage of 20,000 blood samples to facilitate advanced biological research. The project also emphasizes open access to genomic data through the Indian Biological Data Centre (IBDC), fostering collaboration and innovation among researchers.

Researchers aim to develop affordable genome-wide and disease-specific arrays to support low-cost diagnostic solutions and research initiatives within India. This focus on accessibility is intended to translate genomic discoveries into tangible healthcare benefits for a wider population.

Recent Findings and Ongoing Research

New findings from GenomeIndia, as reported by the Observer Research Foundation, point to a more uneven distribution of disease risk and drug response than previously understood. The project has released a flagship genomics manuscript, a companion phenotypic manuscript, a public dashboard for exploratory data use, open code, and extensive supplementary analytical material. However, the two principal papers are currently available as preprints on medRxiv and have not yet undergone peer review, meaning the findings should be interpreted with caution.

The rationale behind GenomeIndia stems from the fact that India represents roughly 18 percent of the world’s population, yet remains underrepresented in global genomic databases and public health research. The project aims to correct this imbalance by providing a detailed genomic profile of the Indian population.

Implications for Precision Medicine

GenomeIndia’s work is expected to significantly advance the field of precision medicine in India. By identifying genetic markers associated with disease risk and drug response, healthcare providers can potentially tailor treatments to individual patients, maximizing effectiveness and minimizing adverse effects.

The project’s focus on developing affordable genetic tools for diagnostics is particularly important for a country with a large and diverse population. Lowering the cost of genetic testing will make it more accessible to individuals across different socioeconomic backgrounds, potentially leading to earlier diagnosis and more effective management of diseases.

The GenomeIndia project represents a significant investment in the future of healthcare in India, with the potential to transform the way diseases are understood, diagnosed, and treated. As the project progresses and more data becomes available, it is expected to provide valuable insights into the genetic basis of health and disease in the Indian population.